Punjab anti-drug activist Jhota's autopsy conducted at PGIMER, cremation on Nov. 8
The autopsy of anti‑drug activist Parvinder Singh Jhota was completed at PGIMER, and his family plans a cremation on November 8 at noon. Religious leader Nihang Raja Raj Singh confirmed the schedule during a public statement.
Parvinder Singh Jhota, a well‑known activist in Punjab who campaigned against the spread of narcotics among youth, died under circumstances that have prompted a formal autopsy at the Postgraduate Institute of Medical Education and Research (PGIMER) in Chandigarh. The medical team conducted a thorough examination to determine the cause of death, and the findings will be released to the family and relevant authorities once the report is finalized. Jhota's work had earned him both admiration and opposition, as he frequently organized community meetings and worked with law‑enforcement agencies to dismantle local drug networks.
Following the autopsy, Jhota's family announced that the cremation will take place on Sunday, November 8, at approximately 12 noon. The ceremony will be held at a local crematorium, and religious leader Nihang Raja Raj Singh, who has been a vocal supporter of Jhota's mission, relayed the details to the media. Community members are expected to gather to pay their respects, and several anti‑drug groups have pledged to continue his advocacy work in his memory. The family has requested privacy during the final rites but has also expressed a desire for the public to remain aware of the ongoing fight against drug abuse.
The incident holds significance for readers across India because Punjab has been a focal point in the national conversation about drug addiction and its social impact. Jhota's death highlights the risks faced by activists who challenge entrenched criminal networks, and it underscores the need for robust legal and health measures to address substance abuse. The public response to his cremation may also influence policy discussions at both state and central levels, as officials consider stronger protections for those working on the front lines of drug prevention.
Comments 0